As prevention trials for Alzheimer’s disease move into asymptomatic populations, identifying older individuals who manifest the earliest cognitive signs of Alzheimer’s disease is critical. Computerized cognitive testing has the potential to replace current gold standard paper and pencil measures and… Continue Reading →
Development of the next generation of Alzheimer’s disease drugs is currently presented in Boston:
The primary objective of a clinical trial should be clearly defined with regard to the target of estimation (estimand) for the efficacy of an investigational drug. The fully specified treatment effect of interest should then determine the data collection, data… Continue Reading →
© 2024 Aging-news